Next Article in Journal
Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options
Next Article in Special Issue
Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain
Previous Article in Journal
A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept
Previous Article in Special Issue
Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity
Pharmaceuticals 2010, 3(1), 110-124; doi:10.3390/ph3010110

Notes on Article Versions

NoteDate
article html file updated18 January 2013 01:22 CET
article html file updated21 January 2013 19:16 CET
article html file updated25 January 2013 20:41 CET
article html file updated28 January 2013 18:05 CET
article html file updated5 February 2013 20:28 CET
article html file updated6 February 2013 16:19 CET
article xml file uploaded28 April 2014 11:00 CEST
article html file updated28 April 2014 11:00 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert